IgG Modulation of Inflammatory Response for Spinal Cord Injury Recovery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for spinal cord injuries (SCI) are inadequate in reducing neurological deficits and improving quality of life, as they fail to effectively address the complex and detrimental inflammatory response while preserving beneficial regeneration processes.
Innovation Solution
Administration of immunoglobulin G (IgG) to promote locomotor recovery, inhibit neuronal degeneration, and facilitate nerve regeneration by modulating the immune response and reducing secondary injury mechanisms.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If anti-inflammatory treatments are administered to reduce secondary injury, then neurological deficit is reduced, but beneficial inflammatory responses that promote regeneration are suppressed
Solution Approach 1:
The patent applies this principle by utilizing the beneficial aspects of the inflammatory response (phagocytic activity, cytokine production for regeneration) while mitigating the harmful aspects (excessive tissue damage, BBB breakdown). IgG modulates the inflammatory response to convert the potentially harmful process into a beneficial one that promotes both protection and regeneration.
Solution Approach 2:
The patent changes the parameters of the immune response by administering IgG, which alters the intensity and duration of inflammatory mediator production. This modulates the inflammatory response to achieve optimal levels that promote regeneration without causing excessive damage, effectively changing the quantitative parameters of the biological process.
2Ease of manufacture
If immune reactive cells are recruited to clear cellular debris, then wound healing is promoted, but by-stander damage to healthy tissue occurs
Solution Approach 1:
IgG acts as an intermediary substance that modulates the interaction between immune reactive cells and tissue. It mediates the inflammatory response by regulating cytokine production and immune cell activity, ensuring that wound healing proceeds without excessive damage to surrounding healthy tissue.
Solution Approach 2:
The patent applies partial action by administering IgG to achieve a moderate, controlled inflammatory response rather than allowing the full excessive inflammatory cascade to proceed. This partial modulation of the immune response is sufficient to promote healing while preventing the harmful effects of uncontrolled inflammation.
3Reliability
If current treatments are used for SCI, then some neurological function is preserved, but quality of life improvement is insufficient
Solution Approach 1:
The patent applies preliminary action by administering IgG in the acute phase following SCI, before secondary injury processes fully develop. This early intervention prevents the cascade of harmful events (BBB breakdown, edema, apoptosis) before they can cause extensive damage, thereby preserving neurological function and improving quality of life outcomes.
Data Source
AI summary
The present invention relates to compositions containing IgG and methods for the promotion of nerve regeneration or prevention or inhibition of neuronal degeneration by IgG to ameliorate the effects of injury, disorder or disease of the nervous system.